Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antigen-specific Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00901342
What this trial is testing

Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Dendreon 104
Early research (Phase 1)UnknownNCT00005992
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03119025
What this trial is testing

Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection

Who this might be right for
Hepatitis C, ChronicLiver DiseasesHepatitis+1 more
Russian Academy of Medical Sciences 10
Not applicableUnknownNCT05930301
What this trial is testing

RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)

Who this might be right for
Cervical
Peihua Lu 12
Testing effectiveness (Phase 2)Study completedNCT04180215
What this trial is testing

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

Who this might be right for
HPV-Related Squamous Cell Carcinoma
Hookipa Biotech GmbH 198
Early research (Phase 1)Study completedNCT00028431
What this trial is testing

Novel Adjuvants for Peptide-Based Melanoma Vaccines

Who this might be right for
Melanoma
University of Southern California 19
Not applicableStudy completedNCT00005907
What this trial is testing

Comparison of Immune Response to Booster Vaccines in Blood Transplant Patients and Healthy Volunteers

Who this might be right for
Active ImmunityHealthyStem Cell Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 55
Early research (Phase 1)Study completedNCT00001382
What this trial is testing

A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT02178670
What this trial is testing

Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine

Who this might be right for
Neoplasms,Ovarian
Fuda Cancer Hospital, Guangzhou 40
Early research (Phase 1)Study completedNCT00324623
What this trial is testing

Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Prof. Serge Leyvraz 8
Not applicableUnknownNCT03185429
What this trial is testing

TSA-DC Vaccine in Treating Patients With Gastrointestinal Solid Tumor

Who this might be right for
Tumor GastricTumor, Colorectal
BGI, China 20
Early research (Phase 1)Study completedNCT00096629
What this trial is testing

Vaccine Therapy in Treating Patients With Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center 15
Post-approval studies (Phase 4)Study completedNCT01290055
What this trial is testing

Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine

Who this might be right for
Yellow Fever
Sri Edupuganti 27
Early research (Phase 1)Study completedNCT00001512
What this trial is testing

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

Who this might be right for
B Cell LymphomaFollicular LymphomaLymphoma
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07245901
What this trial is testing

Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 60
Early research (Phase 1)Ended earlyNCT05277753
What this trial is testing

NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia
Shenzhen Geno-Immune Medical Institute 10
Not applicableStudy completedNCT05158621
What this trial is testing

A Screening Study Targeting Tumor-specific Antigens

Who this might be right for
Metastatic Colorectal CancerStage II/III Colon Cancer
Gritstone bio, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT02084823
What this trial is testing

Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells

Who this might be right for
Neoplasms, Lung
Fuda Cancer Hospital, Guangzhou 40
Early research (Phase 1)Ended earlyNCT05262673
What this trial is testing

NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia
Shenzhen Geno-Immune Medical Institute 10
Early research (Phase 1)UnknownNCT02058680
What this trial is testing

Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients

Who this might be right for
Prostate Cancer
OncBioMune Pharmaceuticals 48
Next Page